Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy
出版年份 2013 全文链接
标题
Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 5, Pages 469-483
出版商
Future Medicine Ltd
发表日期
2013-04-05
DOI
10.2217/pgs.13.31
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia
- (2012) Jonathan M. Flanagan et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Single Nucleotide Polymorphism in theHBBP1Gene in the Human β-Globin Locus is Associated with a Mild β-Thalassemia Disease Phenotype
- (2012) Emily Giannopoulou et al. HEMOGLOBIN
- 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner
- (2012) Nikola Kotur et al. PHARMACOGENOMICS
- KLF10gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients
- (2012) Joseph Borg et al. PHARMACOGENOMICS
- Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
- (2011) R. E. Ware et al. BLOOD
- A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression
- (2011) J. J. Farrell et al. BLOOD
- Transcriptional regulation and pharmacogenomics
- (2011) Marianthi Georgitsi et al. PHARMACOGENOMICS
- Region-Specific Genetic Heterogeneity ofHBBMutation Distribution in South-Western Greece
- (2010) Adamantia Papachatzopoulou et al. HEMOGLOBIN
- Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin
- (2010) Joseph Borg et al. NATURE GENETICS
- Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation
- (2010) Geneviève Galarneau et al. NATURE GENETICS
- Functional analysis of the role of theTPMTgene promoter VNTR polymorphism inTPMTgene transcription
- (2010) Branka Zukic et al. PHARMACOGENOMICS
- The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
- (2009) K. Wahlberg et al. BLOOD
- The roles of ASK family proteins in stress responses and diseases
- (2009) Kazuki Hattori et al. Cell Communication and Signaling
- SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
- (2009) Zongli Xu et al. NUCLEIC ACIDS RESEARCH
- Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients
- (2009) Lisa E. Creary et al. PLoS One
- Pharmacogenomics and Therapeutics of Hemoglobinopathies
- (2008) George P. Patrinos et al. HEMOGLOBIN
- Hydroxyurea for the Treatment of Sickle Cell Anemia
- (2008) Orah S. Platt NEW ENGLAND JOURNAL OF MEDICINE
- DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
- (2008) G. Lettre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More